Rao, A., Rizzieri, D. A., Vanegas, E., Moore, J. O., Gockerman, J. P., Diehl, L. F., … Decastro, C. (2012). Pilot Study of Sorafenib for Myelodysplastic Syndrome. In Blood (Vol. 120, pp. 4948–4948). American Society of Hematology. https://doi.org/10.1182/blood.v120.21.4948.4948

Rao, Arati, David A. Rizzieri, Eduardo Vanegas, Joseph O. Moore, Jon P. Gockerman, Louis F. Diehl, Donna Adams, Julie Warzecho, and Carlos Decastro. “Pilot Study of Sorafenib for Myelodysplastic Syndrome.” In Blood, 120:4948–4948. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.4948.4948.

Rao A, Rizzieri DA, Vanegas E, Moore JO, Gockerman JP, Diehl LF, et al. Pilot Study of Sorafenib for Myelodysplastic Syndrome. In: Blood. American Society of Hematology; 2012. p. 4948–4948.

Rao, Arati, et al. “Pilot Study of Sorafenib for Myelodysplastic Syndrome.” Blood, vol. 120, no. 21, American Society of Hematology, 2012, pp. 4948–4948. Crossref, doi:10.1182/blood.v120.21.4948.4948.

Rao A, Rizzieri DA, Vanegas E, Moore JO, Gockerman JP, Diehl LF, Adams D, Warzecho J, Decastro C. Pilot Study of Sorafenib for Myelodysplastic Syndrome. Blood. American Society of Hematology; 2012. p. 4948–4948.